Societe Generale’s Asterias Biotherapeutics AST Stock Holding History
Bought
Maintained
Sold
Other funds holding AST
SM
Societe Generale's AST Position: Q2 2016 in Review
Societe Generale opened a new position in Asterias Biotherapeutics (AST) in Q2 2016: 22,117 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #2451 among its holdings.
66 funds tracked by Wall St. Rank hold AST as of Q2 2016.
- Societe Generale held 22,117 shares of Asterias Biotherapeutics worth $53K as of Q2 2016.
- Asterias Biotherapeutics was a new Societe Generale position in Q2 2016.
- Asterias Biotherapeutics made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #2451 holding.
- 66 funds tracked by Wall St. Rank held Asterias Biotherapeutics as of Q2 2016.
Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.